Skip to content
DataLookout
Menu

NCT05172011

Understanding the Long-term Impact of COVID on Children and Families

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 1 year 8 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 11 versions: 8 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Apr 1, 2027 to Dec 31, 2028 Show 4 more changesShow less
    • Eligibility criteria expanded, about 50 words
    • Study completion pushed from May 23, 2027 to Sep 30, 2029
    • Site details revised at 13 of 65 sites
    • Publications: details revised at 3 of 3 entries
  2. Notable Primary completion date: Apr 1, 2025 to Apr 1, 2027v8 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 39000 to confirmed 15028
    • Study completion date: May 23, 2025 to May 23, 2027
    • Site details revised at 65 of 65 sites
  3. Minor Enrollment target: 40000 to 39000v7
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 72 to 65
    • Start date changed from estimate of Feb 14, 2022 to Mar 1, 2022
    v5
  5. Minor Study sites: 71 to 72
    • Start date: Jan 18, 2022 to Feb 14, 2022
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Minor Study sites: 69 to 71v3
  2. Minor Study sites: 45 to 69v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Caregiver SARS-CoV-2 Infection Status
Timeframe: Baseline
Child SARS-CoV-2 Infection Status
Timeframe: Baseline
Caregiver Severity of SARS-CoV-2 Infection
Timeframe: Baseline
Child Severity of SARS-CoV-2 Infection
Timeframe: Baseline
Caregiver Previous In-Hospital SARS-CoV-2 Treatment Record
Timeframe: Baseline
Child Previous In-Hospital SARS-CoV-2 Treatment Record
Timeframe: Baseline
Caregiver Symptoms
Timeframe: Baseline, up to Month 48
Child Symptoms
Timeframe: Baseline, up to Month 48
Caregiver SARS-CoV-2 Vaccination Status
Timeframe: Baseline, up to Month 48
Change in Child SARS-CoV-2 Vaccination Status
Timeframe: Week 8, up to Month 48
Change in Caregiver SARS-CoV-2 Treatment Record
Timeframe: Month 12, up to Month 48
Change in Child SARS-CoV-2 Treatment Record
Timeframe: Week 8, up to Month 48

Arms and interventions

Extant, Clinical and De Novo Cohort -- INFECTED

SARS-CoV-2 infected children and young adults with and without current or prior PASC-like symptoms, including infected individuals with history of multisystem inflammatory syndrome in children (MIS-C), and infants born in the context of maternal SARS-CoV-2 infection during pregnancy

Extant, Clinical and De Novo Cohort -- UNINFECTED

SARS-CoV-2 uninfected children and infants born to uninfected mothers

Acute Cohort -- INFECTED

Newly SARS-CoV-2 infected individuals (≤4 weeks since onset of symptoms or positive laboratory testing)

Acute Cohort -- UNINFECTED

Contemporaneous SARS-CoV-2 uninfected individuals selected from the same population as newly SARS-CoV-2 infected individuals

Post-acute cohort -- INFECTED

Post-acute infected individuals (\>4 weeks after initial symptoms or positive laboratory testing) in the extant, clinical and de novo cohorts, including infants born in the context of maternal SARS-CoV-2 infection during pregnancy, will be enrolled 1-24 months after initial SARS-CoV-2 infection.

Post-acute cohort -- UNINFECTED

Uninfected individuals will be derived from a similar population with respect to age, sex, race and ethnicity, geographic origin, sociodemographics, and time of enrollment as the infected individuals.

Post-COVID Vaccine Myocarditis

Individuals with history of myocarditis after receiving COVID-19 vaccine.

Primary Caregivers

The primary caregiver of the child or young adult may optionally participate in the study.

Biological Parent

If the primary caregiver is a biological parent, the other biological parent may optionally participate in the study

Sites

65 sites in 1 country